Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...
Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in ...
MHH Human Genetics is improving the diagnosis of rare diseases in order to tailor treatments for critically ill newborns and children.
Climate Compass on MSN
The 8 breakthroughs that could quietly change everyday life
Most of the developments that end up reshaping daily life don't announce themselves with fanfare. They start in laboratories, ...
Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
For Astellas’ chief manufacturing officer Rao Mantri, Ph.D.—who entered the position a little over a year ago—production is ...
A nasal spray has been found to reverse signs of brain ageing in mouse trials, according to a new paper published in the ...
GLP-1 drugs like Wegovy alone do not work, may benefit more from a combination treatment, a recent review of the evidence ...
This is my fourth BioMarin article following 01/2025's "BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO ...
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...
‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...
The Downstream Processing Market is entering a high-stakes expansion phase driven by surging biopharmaceutical production, ...
Government initiative OASES supports GSK and Tigermed as they expand clinical trials and collaboration in mainland China and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results